Skip to main content
Top
Published in: Clinical Rheumatology 11/2007

01-11-2007 | Case Report

Cardiac sarcoidosis responding to monotherapy with infliximab

Authors: Imad Uthman, Zahi Touma, Maurice Khoury

Published in: Clinical Rheumatology | Issue 11/2007

Login to get access

Abstract

Cardiac involvement is a rare and potentially life-threatening complication of sarcoidosis. We report the case of a young previously healthy woman who presented with complete atrioventricular heart block. Further evaluation revealed non-caseating granulomas in the hilar and mediastinal regions. A pacemaker was inserted, and she was treated with four doses of infliximab after she refused treatment with steroids. Rapid resolution of the pulmonary lymph nodes was documented and repeated interrogations of the pacemaker 1 year after her last infliximab infusion documented that she was in sinus rhythm. Infliximab may be considered as an alternative first-line therapy in sarcoidosis with serious organ involvement.
Literature
1.
go back to reference Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334CrossRef Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334CrossRef
2.
go back to reference Veinot JP, Johnston B (1998) Cardiac sarcoidosis—an occult cause of sudden death: a case report and literature review. J Forensic Sci 43:715–717PubMed Veinot JP, Johnston B (1998) Cardiac sarcoidosis—an occult cause of sudden death: a case report and literature review. J Forensic Sci 43:715–717PubMed
3.
go back to reference Sharma OP (2003) Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest 123:18–19PubMedCrossRef Sharma OP (2003) Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest 123:18–19PubMedCrossRef
4.
5.
go back to reference Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed
6.
go back to reference Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed
7.
go back to reference Prior C, Knight RA, Herold M, Ott G, Spiteri MA (1996) Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 9:47–53PubMedCrossRef Prior C, Knight RA, Herold M, Ott G, Spiteri MA (1996) Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 9:47–53PubMedCrossRef
8.
go back to reference Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620–4627PubMed Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620–4627PubMed
9.
go back to reference Baughman RP, Lower EE (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70–74PubMed Baughman RP, Lower EE (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70–74PubMed
10.
go back to reference Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542–3543PubMedCrossRef Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542–3543PubMedCrossRef
11.
go back to reference Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071PubMedCrossRef Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071PubMedCrossRef
12.
go back to reference Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117:277–279PubMedCrossRef Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117:277–279PubMedCrossRef
13.
go back to reference Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27–31PubMed Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27–31PubMed
14.
go back to reference Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795–802PubMedCrossRef Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795–802PubMedCrossRef
15.
go back to reference Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133–3140PubMedCrossRef Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133–3140PubMedCrossRef
Metadata
Title
Cardiac sarcoidosis responding to monotherapy with infliximab
Authors
Imad Uthman
Zahi Touma
Maurice Khoury
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 11/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0614-1

Other articles of this Issue 11/2007

Clinical Rheumatology 11/2007 Go to the issue